𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular phenotyping of minimal residual disease in solid cancer – Defining the markers for tumor progression?

✍ Scribed by Klaus Pantel

Book ID
119233471
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
41 KB
Volume
4
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[Recent Results in Cancer Research] Mini
[Recent Results in Cancer Research] Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer Volume 195 || Molecular Assays for the Detection and Characterization of CTCs
✍ Ignatiadis, Michail; Sotiriou, Christos; Pantel, Klaus 📂 Article 📅 2012 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 310 KB

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the und

Quantitative monitoring of cyclin D1 exp
Quantitative monitoring of cyclin D1 expression: A molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma
✍ Helena Brizova; Marketa Kalinova; Lenka Krskova; Marcela Mrhalova; Roman Kodet 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 235 KB

## Abstract In mantle cell lymphoma (MCL), minimal residual disease (MRD) is an indicator of the disease outcome. Quantitative methods used so far do not provide a suitable molecular marker in 30–70% patients with MCL (depending on the technique used). We tested cyclin D1 as a marker for quantitati